Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bausch Lomb Corporation (BLCO.TO)

Bausch Lomb Corporation (BLCO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,128,652
  • Shares Outstanding, K 350,992
  • Annual Sales, $ 4,146 M
  • Annual Income, $ -260,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.25
  • Price/Cash Flow N/A
  • Price/Book 0.76
Trade BLCO.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings $-0.15 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Instruments & Suppls

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.04 +7.77%
on 04/12/24
23.59 -13.01%
on 03/27/24
-1.58 (-7.15%)
since 03/22/24
3-Month
18.41 +11.46%
on 02/08/24
23.87 -14.03%
on 02/23/24
+1.15 (+5.94%)
since 01/24/24
52-Week
18.41 +11.46%
on 02/08/24
28.96 -29.14%
on 06/30/23
-2.45 (-10.67%)
since 04/24/23

Most Recent Stories

More News
Stocks in play: Bausch + Lomb Corporation

Announced its ONE by ONE and Biotrue® Eye Care Recycling programs have collected 84,343,540 units, or ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Today announced 15 podium and four poster presentations during the American Society of Cataract and ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Announced its fourth-quarter 2023 financial results. Revenue of $1.173 Billion. GAAP Net Loss Attributable ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Today announced three podium presentations and seven poster presentations during the American Academy ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. launch of LUMIFY EYE ILLUMINATIONS, a new line of hypoallergenic specialty eye care ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Announced its ONE by ONE and Biotrue Eye Care Recycling programs have been recognized as 2023 Sustainability ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalmic solution) for the treatment ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Today announced that Chairman and CEO Brent Saunders is scheduled to participate at the 2023 Wells Fargo ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. launch of PreserVision® AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10). Developed ...

BLCO.TO : 20.52 (+1.03%)
Stocks in play: Bausch + Lomb Corporation

Announced a reshaping of its executive leadership team, including the elevation of all business unit ...

BLCO.TO : 20.52 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed...

See More

Key Turning Points

3rd Resistance Point 20.65
2nd Resistance Point 20.54
1st Resistance Point 20.43
Last Price 20.52
1st Support Level 20.21
2nd Support Level 20.10
3rd Support Level 19.99

See More

52-Week High 28.96
Fibonacci 61.8% 24.93
Fibonacci 50% 23.68
Fibonacci 38.2% 22.44
Last Price 20.52
52-Week Low 18.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar